Depression and diabetes: treatment and health-care delivery (Q38494729)

3 September 2017

1 reference

title

Depression and diabetes: treatment and health-care delivery (English)

1 reference

3 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Alex Brown

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Richard Holt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Frank Petrak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Harald Baumeister

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

17 May 2015

1 reference

The Lancet: Diabetes & Endocrinology

3 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

472-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

Depression and poor glycemic control: a meta-analytic review of the literature

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Diabetes in Primary Care: Prospective Associations between Depression, Nonadherence and Glycemic Control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Association of depression and diabetes complications: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depression and all-cause and coronary heart disease mortality among adults with and without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Effect of race/ethnicity and persistent recognition of depression on mortality in elderly men with type 2 diabetes and depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Association of coexisting diabetes and depression with mortality after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depression Predicts Increased Incidence of Adverse Health Outcomes in Older Mexican Americans With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Increased mortality risk in women with depression and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Quality of life in medically ill persons with comorbid mental disorders: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depression and diabetes treatment nonadherence: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Relationship of depression and diabetes self-care, medication adherence, and preventive care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Quality of depression care in a population-based sample of patients with diabetes and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Constructs of depression and distress in diabetes: time for an appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Psychosocial factors and diabetes mellitus: evidence-based treatment guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Executive summary: Standards of medical care in diabetes--2014

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening for depression in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening for depressive symptoms: validation of the center for epidemiologic studies depression scale (CES-D) in a multiethnic group of patients with diabetes in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Key concepts in screening for depression in people with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Should we screen for depression?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening and case-finding instruments for depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening, evaluation and management of depression in people with diabetes in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Healthcare technician delivered screening of adults with diabetes to improve primary care provider recognition of depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depressive symptoms, not completing a depression screening questionnaire, and risk of poor compliance with regular primary care visits in patients with type 2 diabetes: the Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) study group.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Screening for depression and diabetes-related distress in a diabetes outpatient clinic

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Evidence review: efficacy and effectiveness of antidepressant treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Collaborative care for patients with depression and chronic illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Assessment of diabetes-related distress

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Detecting and monitoring depression with a two-item questionnaire (PHQ-2)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Case-finding instruments for depression. Two questions are as good as many

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Preventing the Onset of Depressive Disorders: A Meta-Analytic Review of Psychological Interventions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Prevention of depression in chronically physically ill adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The link between depression and diabetes: the search for shared mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Treatment of depression in diabetes: an update

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Standards of medical care in diabetes--2014

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Collaborative care for depression in medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

A minimal psychological intervention in chronically ill elderly patients with depression: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

A psychoeducational intervention (SWEEP) for depressed women with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

A randomized trial of telephonic counseling plus walking for depressed diabetes patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

The effectiveness of depression care management on diabetes-related outcomes in older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Economic evaluation of a minimal psychological intervention in chronically ill elderly patients with minor or mild to moderate depression: a randomized trial (the DELTA-study).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Cost-effectiveness of systematic depression treatment among people with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Meta-review of depressive subtyping models

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Impact of an acceptance facilitating intervention on diabetes patients' acceptance of Internet-based interventions for depression: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Anti-inflammatory therapy in chronic disease: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Lifestyle medicine for depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900045-5

7 January 2021

10.1016/S2213-8587(15)00045-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25995125%20AND%20SRC:MED&resulttype=core&format=json

release_vxf735ed6jhz7ip7sfguklhhye

12 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vxf735ed6jhz7ip7sfguklhhye

24 November 2022

mapped directly with Wikidata item

1 reference